InvestorsHub Logo
Followers 164
Posts 12802
Boards Moderated 1
Alias Born 01/26/2016

Re: exwannabe post# 56193

Monday, 03/07/2016 4:25:21 PM

Monday, March 07, 2016 4:25:21 PM

Post# of 693205
exwannabe,

QUOTE:

"BUT changing the endpoints always add to the negative list wrt the trial being run well." exwannabe

That is one way to look at the process but the reality is that science is about learning and a good trial design allows you to learn and adjust. When you can no longer adjust you either have something or you need to start over. One look at all that has been learned over the course of this trial and how NWBO has left options on the table to be able to navigate through it all and you can see why so many believe this company is either the best sham ever or a model for future clinical trials to follow if successful. Best wishes.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News